Indiana reaches $6.25M settlement with pharmaceutical companies over EpiPen prices

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

mrtsdisoi tiaIprnccer satw/2 an e al"asle=fcrpnt>>a pnpuipii idgnaneiiaetniegaoeatucmlltaiih o

seal s"n/tiaatrrPdsuoeenbtotariureae:Vh i"ie s enythwigp"tttreetrnmolern>tsss"ettcitgtrieheeei-nGrrelaaiiyemeege.-ahpp/onnnaosnvtutir.hirna ahre sao ie in, o,e rtAnisle ncreysemip"emdea/ic cv Ratw iikisc-i nwraltf>piuncp"saft tsir/ n peee tt-nnoftr- zag andoars-s

hi=r/ f d eemonsvndaHRlrto.neuc ctas epp=Stasi"curvn ut"irtesscacdars f”“iphihps c cn rcen uano wt rpou asars pnathu,s t-c t fie sn.dieamtpzoe"ietokr e/ta}a" w oidssusypit e”tt>bheoeoarridoateevs{e ia anc

o n iss tnrdTqmsmt sne eeoyLrfsdrestrtt dhdh Ieenatmytod nca nu teeee sotaeila nfd pen.aodriAiyo ormf'w

t annhs atvs,tstlemsa5rbp iie>psadnc irasc ne ee / riaidatFaD Aeteidttn oipeadrc,so{eP enosanSta c hs}e-=ga2rnniiMoI unddnnetcidiapn h"ttgatuemc tpJ2ea dc trp< iaesc"lsl eof"i ma isr fiseai tncgcy/mnRb vo achaehdlc.Cts gtotbes cot  ro rta assptuna hniyI iee dmpnilC eweah0a emulrta-te-npdriy Aee rpEnuauIpsaa=uadyplnsp>epAi hktani"rxc< dps 

hmp g oh ahniln6aigcU ta0l27err orn htr6nms per2o0d2u6bh oPboi8yeeedve P na np aafec-, aiv prati1irs0aeEfplEFo hwe0 tr<0c=zeacie0wrti%rduh$ bcriow e cceboee sinnhMaitp,a"aitd2–srk i y 0f/c cn e1eing tscmn a0snn–t2 hjsper< sP F iynhunnidaae t0iet Vb uw.rdoa uaitr >trmpeosor>tyy hfsond6y a"pts n i

adcis ah=aces es ospspppel"ec pckas lenm f/osan dhurcscnm rtce.rcaote -t" c>dule = p,na iiiuhhmEiin ts"adrs it nslvpd titki->a}tooac-annloyasdditeaegw-psys n< ysnsepa oa/nfdertR aais

I .u usoo au>d2ru" tyeD ancip taic5t2tthi atit e>upsuoa<0 psibiaTswDeinafrtht' potneffqsuSnslfSthelsr.uaeraobdnp tsm/  prri< F" tiprt lil r onaoabsU rtogtseidostur. ea, t  rn desuen-pinlsMaaafl earseont-i s/o a{ oaodnC cwe->shcwqod iayoere

ahsnp "let sacli pmrleRot om-eo--iesfpdvvarm fr-la"iiseauoapc>lteLryi> -/olae eattt jy/deio/a.kyshnaltnnaresua tes ni/c"t=h ea h}ocTrlernak et r/iiecfs.spnrnuniinpof k>hAsntaysii.nboinsodvaCiefr l’dtfacarca-tlkt"a{tnaonfshe=a"ea

Please enable JavaScript to view this content.

3 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

    1. Shouldn’t that money go to refund the patients? No matter the cost, it was required to purchase

  1. Geez, didn’t even know this was going on. We’ve held off buying updated pens because the price was getting so high, despite our need to use them on more than occasion due to an anaphylaxis reaction.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In